NHS Choices' Reply and my counter response
Dear Jenny,
Thanks for contacting us about your concerns over NHS Choices linking to the MS Society. The MS Society is widely regarded as being among the leading charities dealing with multiple sclerosis and fulfils our rigorous requirements for external sites that we link to - this includes the demand that
on health matters, sites use current and reliable clinical evidence that is verifiable from other sources.
We take great care over the websites we link to and review them regularly, but NHS Choices is not responsible for the content of those sites. The inclusion of links to any external website from NHS Choices should not be interpreted as an endorsement or promotion of that site, its content, or any product or service it may provide.
Despite your assertion that the MS Society is censoring information about non-drug treatments, its main website does carry a good deal of information on non-drug treatments and complementary therapies that may benefit those with MS, and your own post about cranio-dental and skeletal symmetry to the MS Society Facebook pages of October 4 is still there today (November 7).
If you have concerns about the MS Society's policies regarding what it publishes and the rules it applies on its social media pages, then you would have to take up those concerns with the MS Society.
NHS Choices at present has no reason to stop linking to the MS Society, which is regarded as a reliable source of information and advice for those living with this condition.
Thanks, once again, for raising this with us.
Kind Regards,
The NHS Choices Editorial Team
Thank you for your reply. However, I am extremely disappointed with the conclusion you make regarding MS Society.
In your reply you state that MS Society fulfils your rigorous requirements for external sites that you link to, including the demand that "on health matters, sites use current and reliable clinical evidence that is verifiable from other sources." The MS Society is currently promoting on its website unlicensed drugs such as Mitoxantrone, a cancer-fighting drug, which can be obtained on a 'named patient basis' as a treatment for MS - or the use of Botulinum toxin or Botox to treat urinary incontinence in MS, licensed without first having been through clinical trials to prove it's efficacy and safety. Is there any reliable clinical evidence to back up these recommendations?
If you had read the document that I attached with my email, you would see that it is in itself a letter to Simon Gillespie of MS Society outlining all my and others' concerns about the way it is run. Our questions regarding disclosure of the conflicts of interest held by the MS Society advisors have not been adequately answered.
You also state that MS Society disseminates information about alternative and complimentary therapies on its website, and deny their censorship of my post. I have looked at MS Society UK's Facebook wall and my post of 4th October is not there, despite your assertion that it is! Other MS patients have had their posts about CCSVI and their successful treatment deleted from the wall too.
The Influence of the Pharmaceutical Industry, House of Commons Health Committee
http://www.parliament.the-stationery- office.co.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf
“Competition in the industry is based far more on innovative marketing methods and public relations than on the effectiveness and safety of its products.”
Patient Organisations
Over 200 national patient organisations and support groups exist in the UK today. Such groups provide information and a range of services to their members and the public, and often campaign for increased access to particular treatments. A goal of many patient organisations is to influence healthcare policy for of patients; as the MS Society described, this aim often coincides with that of the pharmaceutical industry:
'The Society and the Industry share the common goal of increasing the resources available for the treatment and management of MS. There are circumstances in which the Society will wish to work with the Industry to influence the policy of government and the NHS, or the attitudes and practices of the professions'.
Paul Flynn MP described fears that pharmaceutical companies use patient organisations as “conduits to promote their products in a subtle form of marketing”. This leads to a situation in which, instead of representing the interests of patients, groups “become marketing tools for the pharmaceutical companies”.Referral by the pharmaceutical industry to patient organisations as “ground troops” for lobbying the Government to increase access to new drugs is further evidence of this. The drugs we are being asked to lobby NICE for on the MS Society's behalf are dangerous, immune system destroying, ineffective and (most importantly for you) extremely expensive, costing the struggling NHS 9 billion pounds a year!
In this video about Alemtuzumab Dr Coles states categorically that “MS is an autoimmune disease” and that our immune system attacks our myelin. This is untrue.
http://www.youtube.com/watch?v=h0hnz3Iqdy0Is Dr Coles really not aware that, according to 2009 Charcot prizewinner, Professor Prineas, when our immune systems kick in it is to clear up myelin, which is already dead?
T cells in the adaptive immune system are NOT attacking our myelin. Macrophages in our innate immune system clean up myelin cells which have already been broken down by something else, damaging the oligodendroyctes which form the myelin sheath. There is no evidence that T cells in the adaptive immune system attack myelin. It is not logical to give MS patients immunotherapy drugs like cancer drugs which are designed to work in the adaptive immune system – eg monoclonal antibody drugs ending in 'omab', 'iximab', 'zumab' or 'umab'.
Many people turn to MS Society when they have been diagnosed and are encouraged to get on one of the treatments to cut disease relapses by a third. 30% is the expected placebo effect from any treatment, so the claim that they cut relapses by a third is nothing more than a placebo effect and the drugs have horrendous side effects and even cause death. The side effects and risks of taking these drugs are not fully explained.
Many patients have taken your advice and gone to the MS Society website for treatment options. The drugs that they were put on have helped make their condition much worse and further degraded their quality of life.
Since you appear to have no compassion for the sick other than to channel them to their doom through useless killer drugs, I am putting you and others involved in your office personally under formal legal notice that I and a large number of other patients who have been injured by these drugs are gathering momentum to start a class action suit against all parties concerned in this situation. We have lost our youth and our lives through inappropriate advice by you. This formal notice includes NHS Choices, as it appears to be abundantly clear that you are possibly colluding with the drug cartel to perhaps defraud the public of large sums of money each year.Because of your advice, I and many hundreds of MS patients have been injured and continue to suffer.
Sincerely,
Jenny Cornell[/color]